Clinical Trial Update: Comparative Immunogenicity Study of Two Hepatitis A Vaccines [Phase 4]

View source ↗

Summary

Phase 4 comparative immunogenicity study of two Hepatitis A vaccines sponsored by China National Biotec Group; the status/results are not provided in the docume…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• CNBG HepA vaccine candidate 1
• CNBG HepA vaccine candidate 2

Snippet

Sponsor: China National Biotec Group Company Limited | Conditions: Hepatitis A | Phase 4 | Status: UNKNOWN